(Q34537518)

English

Is inhibition of cyclooxygenase required for the anti-tumorigenic effects of nonsteroidal, anti-inflammatory drugs (NSAIDs)? In vitro versus in vivo results and the relevance for the prevention and treatment of cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 August 2017

1 reference

Europe PubMed Central

Is inhibition of cyclooxygenase required for the anti-tumorigenic effects of nonsteroidal, anti-inflammatory drugs (NSAIDs)? In vitro versus in vivo results and the relevance for the prevention and treatment of cancer (English)

1 reference

Europe PubMed Central

2 August 2017

author name string

Amiram Raz

1

1 reference

Europe PubMed Central

2 August 2017

language of work or name

0 references

publication date

1 February 2002

1 reference

Europe PubMed Central

2 August 2017

Biochemical Pharmacology

1 reference

Europe PubMed Central

2 August 2017

63

1 reference

Europe PubMed Central

2 August 2017

3

1 reference

Europe PubMed Central

2 August 2017

343-347

1 reference

Europe PubMed Central

2 August 2017

Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900857-7

7 January 2021

Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effects on cell cycle and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900857-7

7 January 2021

Sulindac sulfide inhibits the proliferation of colon cancer cells: diminished expression of the proliferation markers PCNA and Ki-67

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900857-7

7 January 2021

Effect of aspirin on induction of apoptosis in HT-29 human colon adenocarcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900857-7

7 January 2021

Sulindac sulfide induces several subpopulations of colon cancer cells, defined by PCNA/Ki-67 and DNA strand breaks

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900857-7

7 January 2021

Sulindac sulfide alters the expression of cyclin proteins in HT-29 colon adenocarcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900857-7

7 January 2021

Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900857-7

7 January 2021

Exisulind (sulindac sulfone) suppresses growth of human prostate cancer in a nude mouse xenograft model by increasing apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900857-7

7 January 2021

Effects of sulindac and its metabolites on growth and apoptosis in human mammary epithelial and breast carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900857-7

7 January 2021

Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900857-7

7 January 2021

The mechanisms of action of nonsteroidal antiinflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900857-7

7 January 2021

Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900857-7

7 January 2021

Malignant transformation and antineoplastic actions of nonsteroidal antiinflammatory drugs (NSAIDs) on cyclooxygenase-null embryo fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900857-7

7 January 2021

Sodium salicylate induces apoptosis via p38 mitogen-activated protein kinase but inhibits tumor necrosis factor-induced c-Jun N-terminal kinase/stress-activated protein kinase activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900857-7

7 January 2021

Inhibition of NF-kappa B by sodium salicylate and aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900857-7

7 January 2021

Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900857-7

7 January 2021

Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900857-7

7 January 2021

Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900857-7

7 January 2021

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900857-7

7 January 2021

Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900857-7

7 January 2021

Meloxicam inhibits the growth of colorectal cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900857-7

7 January 2021

Is inhibition of cyclooxygenase required for the chemopreventive effect of NSAIDs in colon cancer? A model reconciling the current contradiction

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900857-7

7 January 2021

Treatment and survival study in the C57BL/6J-APC(Min)/+(Min) mouse with R-flurbiprofen

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900857-7

7 January 2021

Pure enantiomers of 2-arylpropionic acids: tools in pain research and improved drugs in rheumatology

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900857-7

7 January 2021

The metabolic chiral inversion of 2-arylpropionic acids—a novel route with pharmacological consequences

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900857-7

7 January 2021

Identifiers

10.1016/S0006-2952(01)00857-7

1 reference

Europe PubMed Central

2 August 2017

1 reference

Europe PubMed Central

2 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34537518&oldid=1958443051"